Marcello Damiani
Director/Board Member bei BENEVOLENTAI
Profil
Marcello Damiani is currently the Director at Cellarity Inc., the Independent Non-Executive Director at BenevolentAI SA, and the Chief Digital & Operational Excellence Officer at ModernaTX, Inc. Previously, he worked as the Chief Information Officer & Senior Vice President at bioMérieux SA from 2009 to 2015, and as the Chief Digital & Operational Excellence Officer at Moderna, Inc. from 2015 to 2022.
Mr. Damiani has a graduate degree from Université Fédérale Toulouse Midi-Pyrénées, an MBA from Trium Global Emba, and both undergraduate and graduate degrees from Institut d'Administration Des Entreprises De Toulouse.
Aktive Positionen von Marcello Damiani
| Unternehmen | Position | Beginn |
|---|---|---|
| BENEVOLENTAI | Director/Board Member | 04.05.2023 |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Cellarity Inc.
 Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Director/Board Member | 01.01.2019 |
Ehemalige bekannte Positionen von Marcello Damiani
| Unternehmen | Position | Ende |
|---|---|---|
| MODERNA, INC. | Corporate Officer/Principal | 01.01.2022 |
| BIOMÉRIEUX | Chief Tech/Sci/R&D Officer | 01.01.2015 |
Ausbildung von Marcello Damiani
| Institut d'Administration Des Entreprises De Toulouse | Graduate Degree |
| Trium Global Emba | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BIOMÉRIEUX | Health Technology |
| MODERNA, INC. | Health Technology |
| BENEVOLENTAI | Health Technology |
| Private Unternehmen | 2 |
|---|---|
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Health Technology |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Health Technology |
